Home / Brands / OSSTEM Implant
OSSTEM Implant Recalls
3 recalls on record · November 12, 2025 to November 12, 2025 · Medical Devices
November 12, 2025Medical DevicesFDA
OSSTEM Implant Co., Ltd. recalls Osstem Dental X-Ray System T2Plus. Product Model Numbers T2-C-P and T2-CS-P.
Hazard: Osstem Implant Co. Ltd, is voluntarily initiating a medical device correction involving the current labeling for this electronic product may be missing a required Certification Statement under 21 CFR Subchapter J (Radiological Health Regulations). Specifically, the following statement may have been omitted: Certification Statement: This electronic product complies with all applicable performance standards prescribed under 21 CFR Subchapter J, as enforced by the U.S. Food and Drug Administration at the date of manufacturing.
November 12, 2025Medical DevicesFDA
OSSTEM Implant Co., Ltd. recalls Osstem Dental X-Ray System T2. Product Model Numbers T2-C and T2-CS.
Hazard: Osstem Implant Co. Ltd, is voluntarily initiating a medical device correction involving the current labeling for this electronic product may be missing a required Certification Statement under 21 CFR Subchapter J (Radiological Health Regulations). Specifically, the following statement may have been omitted: Certification Statement: This electronic product complies with all applicable performance standards prescribed under 21 CFR Subchapter J, as enforced by the U.S. Food and Drug Administration at the date of manufacturing.
November 12, 2025Medical DevicesFDA
OSSTEM Implant Co., Ltd. recalls Osstem Dental X-Ray System T1. Product Model Numbers T1-C and T1-CS.
Hazard: Osstem Implant Co. Ltd, is voluntarily initiating a medical device correction involving the current labeling for this electronic product may be missing a required Certification Statement under 21 CFR Subchapter J (Radiological Health Regulations). Specifically, the following statement may have been omitted: Certification Statement: This electronic product complies with all applicable performance standards prescribed under 21 CFR Subchapter J, as enforced by the U.S. Food and Drug Administration at the date of manufacturing.